Skip to content
10-Q

Quarterly Report

PROTECT PHARMACEUTICAL Corp

0001165527-17-000132

← back to feed
Filed
May 19, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · May 19, 2017 1.11M sh
Operating Cash Flow Q1 2017 · Mar 31, 2017 $0
Operating Cash Flow restated Q1 2017 · Mar 31, 2016 −$2.09K
Cash And Equivalents Q1 2017 · Mar 31, 2017 $0
Cash And Equivalents Q1 2017 · Dec 31, 2016 $0
Cash And Equivalents Q1 2017 · Mar 31, 2016 $15
Cash And Equivalents Q1 2017 · Dec 31, 2015 $7
Stockholders Equity Q1 2017 · Mar 31, 2017 −$36.23K
Stockholders Equity Q1 2017 · Dec 31, 2016 −$20.83K
Current Liabilities Q1 2017 · Mar 31, 2017 $36.23K
Current Liabilities Q1 2017 · Dec 31, 2016 $20.83K
Total Liabilities Q1 2017 · Mar 31, 2017 $36.23K
Total Liabilities Q1 2017 · Dec 31, 2016 $20.83K
Total Assets Q1 2017 · Mar 31, 2017 $0
Total Assets Q1 2017 · Dec 31, 2016 $0
Revenue Q1 2017 · Mar 31, 2017 $0
Revenue Q1 2017 · Mar 31, 2016 $0
Sga Expense Q1 2017 · Mar 31, 2016 $92
Net Income Q1 2017 · Mar 31, 2016 −$3.67K
Operating Income Q1 2017 · Mar 31, 2016 −$3.67K